Can-fite Biopharma LTD F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
AMEX
Can-Fite BioPharma Ltd. filed an amended prospectus for a best-efforts public offering of American Depositary Shares and various warrants, aiming to raise capital for research, development, and general corporate purposes.
AMEX
F-1: Can-Fite BioPharma Files F-1 for Up to $10.4 Million Securities Offering Amidst Dilution Concerns
Can-Fite BioPharma Ltd. has filed an F-1 registration statement to offer up to 4,901,961 American Depositary Shares and accompanying warrants in a best-efforts offering, aiming to raise approximately $4.20 million in net proceeds for research and development and general corporate purposes.